Acute Presentation of Tuberculosis Empyema in a Healthy Adolescent.
Journal
The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566
Informations de publication
Date de publication:
12 Sep 2023
12 Sep 2023
Historique:
medline:
13
9
2023
pubmed:
12
9
2023
entrez:
12
9
2023
Statut:
epublish
Résumé
BACKGROUND Tuberculosis (TB) was the leading cause of infectious death worldwide until the COVID-19 pandemic, which reduced case reporting and disrupted TB diagnosis and services. While Mycobacterium tuberculosis remains a leading cause of morbidity and mortality globally, the disease burden within developed nations remains relatively rare. Although the many complications of TB are well known, no current data exists on those infected with TB who subsequently developed recurrent TB empyema, as it is such a rare complication, especially in pediatric and adolescent populations. CASE REPORT A previously healthy 15-year-old male patient presented with 5-day duration of cough, congestion, intermittent fever, and post-tussive emesis. Although born in the United States, 3 months before presentation, he returned from Senegal, where he had lived for 4 years. Imaging demonstrated consolidation with loculated effusion. Patient underwent video-assisted thoracoscopy and chest tube placement, draining 750 mL of purulent fluid testing positive for rare acid-fast bacilli. Rifampin, isoniazid, pyrazinamide, and ethambutol were administered, with discharge medication compliance ensured by daily videos surveillance through the Department of Health. Although compliant with medications, patient presented to the Emergency Department 2 months later with a multi-loculated fluid recollection and fistula formation requiring chest tube placement. After this discharge, patient experienced resolution of disease following completion of therapy. CONCLUSIONS TB complication should be considered as a differential diagnosis for pleural effusion in the appropriate clinical setting. Providers should not only consider the diagnosis but pursue appropriate testing and management early, particularly in those with risk factors, including travel to an endemic location.
Identifiants
pubmed: 37697641
pii: 939419
doi: 10.12659/AJCR.939419
pmc: PMC10505039
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e939419Références
Am J Respir Crit Care Med. 2014 Nov 1;190(9):1044-52
pubmed: 25265362
Emerg Infect Dis. 2020 Mar;26(3):533-540
pubmed: 32091367
Thorax. 2005 Feb;60 Suppl 1:i1-21
pubmed: 15681514
Clin Infect Dis. 2002 Feb 15;34(4):434-40
pubmed: 11797168
Respir Med Case Rep. 2019 Apr 17;27:100848
pubmed: 31049284
PLoS One. 2016 Oct 27;11(10):e0165428
pubmed: 27788218
Ann Thorac Med. 2019 Apr-Jun;14(2):134-140
pubmed: 31007765
Turk Thorac J. 2015 Jan;16(1):1-9
pubmed: 29404070
Open Forum Infect Dis. 2021 Aug 25;8(9):ofab435
pubmed: 34676276
Am J Respir Crit Care Med. 1998 Dec;158(6):1871-5
pubmed: 9847280